Risks and Benefits of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Cancer: A Systematic Review and Meta-Analysis
Emma Grigor(University of Ottawa), Manoj M. Lalu(Institute on Governance), Harold Atkins(University of Ottawa), Justin Presseau(Ottawa Hospital), Mads Daugaard(University of British Columbia), Brian Hutton(Ottawa Hospital), Dean Fergusson(Ottawa Hospital), Robert A. Holt(University of British Columbia), Kednapa Thavorn(University of Ottawa), Matthew D. Seftel(CancerCare Manitoba), Joshua Montroy(University of Ottawa), Natasha Kekre(Ottawa Hospital)
Cited by 190
Related Papers
The Sequence of the Human Genome
|Science|2001|13.7k
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
|Annals of Internal Medicine|2015|8.2k
The Immune Landscape of Cancer
|Immunity|2018|6.3k